Daiichi Sankyo Co., Ltd.
(Tokyo Stock Exchange : DSKYF)

( )
DSKYF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. 0.50%17.956.5%$165.52m
HZNPHorizon Therapeutics Plc 0.92%50.356.5%$147.38m
CTLTCatalent, Inc. 1.79%78.012.3%$137.86m
MYOKMyoKardia, Inc. 0.93%103.981.8%$133.26m
BHCBausch Health Cos., Inc. -1.25%18.920.0%$126.10m
VRXValeant Pharmaceuticals International, Inc. -1.25%18.9214.1%$111.33m
UTHRUnited Therapeutics Corp. 2.31%123.0614.3%$75.79m
ICPTIntercept Pharmaceuticals, Inc. 2.50%75.3816.8%$63.01m
ARGXargenx SE 3.24%232.720.0%$58.54m
JAZZJazz Pharmaceuticals Plc -1.26%117.872.4%$58.01m
GWPHGW Pharmaceuticals Plc 2.00%127.276.2%$54.97m
AMRNAmarin Corp. Plc 1.79%6.831.6%$53.51m
AXSMAxsome Therapeutics, Inc. -1.55%75.801.9%$47.31m
PRGOPerrigo Co. Plc 1.66%56.366.8%$43.30m
ICLRICON plc 0.71%170.944.3%$41.94m

Company Profile

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.